Cargando…
Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical va...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174273/ https://www.ncbi.nlm.nih.gov/pubmed/33599143 http://dx.doi.org/10.1161/JAHA.120.018971 |
_version_ | 1783702872850956288 |
---|---|
author | Ngendahimana, David K. Deo, Salil V. Sundaram, Varun Lentine, Krista L. Herzog, Charles A. Al Dahabreh, Laith Srinivas, Titte R. Chavin, Kenneth D. Sarabu, Nagaraju |
author_facet | Ngendahimana, David K. Deo, Salil V. Sundaram, Varun Lentine, Krista L. Herzog, Charles A. Al Dahabreh, Laith Srinivas, Titte R. Chavin, Kenneth D. Sarabu, Nagaraju |
author_sort | Ngendahimana, David K. |
collection | PubMed |
description | BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. METHODS AND RESULTS: We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. CONCLUSIONS: For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis. |
format | Online Article Text |
id | pubmed-8174273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81742732021-06-11 Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection Ngendahimana, David K. Deo, Salil V. Sundaram, Varun Lentine, Krista L. Herzog, Charles A. Al Dahabreh, Laith Srinivas, Titte R. Chavin, Kenneth D. Sarabu, Nagaraju J Am Heart Assoc Original Research BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. METHODS AND RESULTS: We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. CONCLUSIONS: For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis. John Wiley and Sons Inc. 2021-02-18 /pmc/articles/PMC8174273/ /pubmed/33599143 http://dx.doi.org/10.1161/JAHA.120.018971 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Ngendahimana, David K. Deo, Salil V. Sundaram, Varun Lentine, Krista L. Herzog, Charles A. Al Dahabreh, Laith Srinivas, Titte R. Chavin, Kenneth D. Sarabu, Nagaraju Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title | Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title_full | Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title_fullStr | Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title_full_unstemmed | Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title_short | Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection |
title_sort | outcomes of surgical mitral and aortic valve replacements among kidney transplant candidates: implications for valve selection |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174273/ https://www.ncbi.nlm.nih.gov/pubmed/33599143 http://dx.doi.org/10.1161/JAHA.120.018971 |
work_keys_str_mv | AT ngendahimanadavidk outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT deosalilv outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT sundaramvarun outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT lentinekristal outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT herzogcharlesa outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT aldahabrehlaith outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT srinivastitter outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT chavinkennethd outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection AT sarabunagaraju outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection |